After rejection, FDA approves Telix’s Pixclara, the first FET-PET imaging drug for brain cancer Read more 

GSK doubles down on Chimagen with $750M multiple myeloma wager Read more 

Novo walks away from $285M pact to develop monthly GLP-1 obesity drug with Ascendis Read more 

Go to Top